Dentsply Sirona (XRAY) shares are soaring 10.31% in pre-market trading on Thursday following the release of its impressive first-quarter 2025 financial results. The dental equipment and supplies manufacturer significantly outperformed analyst expectations, demonstrating robust growth and operational efficiency.
The company reported adjusted earnings per share (EPS) of $0.43, handily beating the analyst estimate of $0.29-$0.30. This represents a substantial 43% surprise to the upside. Revenue for the quarter came in at $879 million, surpassing the consensus estimate of $854.75-$855.2 million, showcasing strong demand for Dentsply Sirona's products and services.
Adding to the positive sentiment, Dentsply Sirona announced that it is maintaining its fiscal year 2025 outlook for organic sales and adjusted EPS. Furthermore, the company raised its full-year 2025 sales guidance to a range of $3.6 billion to $3.7 billion, up from its prior range of $3.5 billion to $3.6 billion. This decision suggests confidence in the company's ability to sustain its growth trajectory and meet its financial targets for the year, despite potential market uncertainties. As investors digest these encouraging results and improved outlook, the stock's pre-market jump indicates heightened optimism about Dentsply Sirona's future prospects in the dental industry.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.